Literature DB >> 21661432

Transarterial embolization for ruptured hepatocellular carcinoma: survival predictors.

Nobuyuki Toshikuni1, Yoshitaka Takuma, Youichi Morimoto, Hiroyuki Shimomura, Hiroshi Yamamoto.   

Abstract

BACKGROUND/AIMS: Survival predictors in patients with ruptured hepatocellular carcinoma (HCC) treated by transarterial embolization (TAE), have not been fully investigated.
METHODOLOGY: Predictors of short-term (< or = 30 days) and long-term (>30 days) survival were evaluated by using the logistic regression model and the Cox proportional hazard model, respectively.
RESULTS: Forty-eight patients treated by emergency TAE were enrolled. The median survival time was 231 days. Although hemostasis was attained by TAE in 44 patients (91.7%), 15 patients (31.3%) died within 30 days. In a multivariate analysis, low serum creatinine level (p=0.018) was the only significant predictor of increased short-term survival. Of the 33 patients who survived more than 30 days after TAE, he patic resection was performed in 8, transarterial chemoembolization or chemotherapy in 8, and conservative treatment in 17. In a multivariate analysis, among the 33 who survived, unilateral location of tumors (p=0.041) and low a-fetoprotein level (p=0.004) were significant predictors of increased long-term survival.
CONCLUSIONS: Short-term survival of patients with ruptured HCC who were treated by TAE depended on serum creatinine level on arrival. Long-term survival of patients who survived more than 30 days after TAE, was influenced by tumor location and a-fetoprotein level.

Entities:  

Mesh:

Year:  2011        PMID: 21661432

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma.

Authors:  Wei Zhang; Zhi-Wei Zhang; Bi-Xiang Zhang; Zhi-Yong Huang; Wan-Guang Zhang; Hui-Fang Liang; Xiao-Ping Chen
Journal:  J Gastrointest Surg       Date:  2018-09-04       Impact factor: 3.452

2.  MELD‑Na and short-term outcome of patients with ruptured hepatocellular carcinoma receiving transarterial embolization.

Authors:  Lei Duan; Bo-Han Zhang; Jia-Xu Liao; Xiao-Hua Zheng
Journal:  Abdom Radiol (NY)       Date:  2022-01-07

3.  MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization.

Authors:  Michael C Jundt; Robert L Owen; Scott M Thompson; Chad J Fleming; Andrew H Stockland; James C Andrews
Journal:  Abdom Radiol (NY)       Date:  2021-10-11

4.  Gelatin sponge microparticles for the treatment of the spontaneous rupture of hepatocellular carcinoma hemorrhage.

Authors:  Pu Zhao Wu; Jun Zhou; Yue Wei Zhang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

5.  The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients.

Authors:  Ao Huang; De-Zhen Guo; Yu-Peng Wang; Jia Fan; Xin-Rong Yang; Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-03       Impact factor: 4.322

6.  Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era.

Authors:  Tan To Cheung; Ronnie T P Poon; Kenneth S H Chok; Albert C Y Chan; Simon H Y Tsang; Wing Chiu Dai; Thomas C C Yau; See Ching Chan; Sheung Tat Fan; Chung Mau Lo
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

7.  Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study.

Authors:  Hanteng Yang; Kefei Chen; Yongang Wei; Fei Liu; Hongyu Li; Zhipeng Zhou; Bo Li
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.